Reporter enzyme fluorescence (REF) utilizes substrates that are specific for enzymes present in target organisms of interest for imaging or detection by fluorescence or bioluminescence. We utilize BlaC, an enzyme expressed constitutively by all M. tuberculosis strains. REF allows rapid quantification of bacteria in lungs of infected mice. The same group of mice can be imaged at many time points, greatly reducing costs, enumerating bacteria more quickly, allowing novel observations in host-pathogen interactions, and increasing statistical power, since more animals per group are readily maintained. REF is extremely sensitive due to the catalytic nature of the BlaC enzymatic reporter and specific due to the custom flourescence resonance energy transfer (FRET) or fluorogenic substrates used. REF does not require recombinant strains, ensuring normal host-pathogen interactions. We describe the imaging of M. tuberculosis infection using a FRET substrate with maximal emission at 800 nm. The wavelength of the substrate allows sensitive deep tissue imaging in mammals. We will outline aerosol infection of mice with M. tuberculosis, anesthesia of mice, administration of the REF substrate, and optical imaging. This method has been successfully applied to evaluating host-pathogen interactions and efficacy of antibiotics targeting M. tuberculosis.
Introduction
The slow growth rate of M. tuberculosis is a major roadblock in rapid diagnosis of tuberculosis 1, 2, 3 . While culture based diagnosis takes weeks to produce results, acid-fast smear has diagnostic limitations 4 in children 5 and patients co-infected with human immunodeficiency virus 6, 7 . Optical imaging technologies have recently been recognized as an alternative to traditional diagnostic methods for tuberculosis 8, 9 . Fluorescence and bioluminescence can be used to optically image M. tuberculosis in live animals in real-time 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 . Optical imaging has the benefit of a rapid and specific assessment of an infection with M. tuberculosis 20, 21, 22 .
We outline details for optical imaging of M. tuberculosis in live mice using REF. This method is very specific and sensitive 23, 24 and, similar to other optical methods, is less expensive than other methods of tuberculosis (TB) imaging 25 , including computed tomography (CT) 26 , magnetic resonance imaging (MRI) 27 , and F-fluorodeoxyglucose positron emission tomography/CT (F-FDG PET/CT) 28 . REF utilizes custom fluorescent or bioluminescent substrates that upon cleavage by a bacterial enzyme, produce a fluorescent product 8, 29 . Hence, it has the advantage of not requiring a recombinant mycobacterial reporter strain 30, 31 . The FRET substrate described is comprised of a fluorochrome and a quencher connected by a β-lactam ring that is hydrolyzed by BlaC (β-lactamase), naturally constitutively expressed by tuberculosis-complex Mycobacterium 8, 32 . The bacteria directly generate signal due to REF catalytic activity that allows amplification by many orders of magnitude and sensitive detection of M. tuberculosis.
The REF substrate used in this study has excellent tissue penetration in live animals and reduced background due to its long wavelength. With this long-wavelength substrate it is possible to achieve a threshold of detection for M. tuberculosis of nearly 100 colony forming units (CFU) in vitro and <1000 CFU in the lungs of mice in vivo (whole animal) 8, 33 Copyright © 2018 Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License February 2018 | 132 | e56801 | Page 3 of 7 13 . Leave the mice in the anesthesia induction chamber for 5 -10 min until completely anesthetized. 14. Once the mice are anesthetized, apply an optical ointment to the eyes to protect them while imaging. 15 . Place the mice in ventral or sternal recumbency such that their noses are placed in the nose cone to facilitate anesthesia of mice during the imaging procedure.
Reporter enzyme fluorescence (REF) imaging
1. Inject the substrate (20 µM, 2.5 µL/g of weight) by intraperitoneal injection into the infected as well as the control mice. The mice are under anesthesia inside the imaging chamber for less than 1 min. 2. Start the imaging system. 3. Initialize the system by clicking on Initialize. Wait until the temperature bar turns to green.
NOTE: The imaging chamber consists of a heated platform to maintain body temperature of the animal while imaging. 4. For imaging acquisition setting, select Fluorescent | Trans-illumination for whole animal or Epi-illumination for lung tissues, Structure and Overlay in Acquisition Control Panel. 5. Set Field of view to B for single mouse and lamp level to high. 6. Set exposure time to auto, medium binning, 2 -3 for the f/stop, and excitation filter at 745 nm and emission filters from 780 nm to 840 nm. 7. For sequence setup, click on Sequence Setup, select 9 -12 Trans-illumination points in the lung area. 8. Click on Acquire for image acquisition. 9. Place the mouse back into the cage post-imaging. 10. Monitor the mice until fully recovered or sacrifice for quantifying CFU if imaging at a time-point of the experiment. Perform a modified Karnofsky score to monitor the well-being of mice post-imaging. 14. Save and/or export the result of FLIT 3D reconstruction analysis into a figure or data file.
Analysis of REF imaging

Quantification of bacteria by CFU
1. Euthanize the mice by intraperitoneal injection of 0.1 mL pentobarbital sodium (390 mg/mL). 2. Check for pedal reflex by squeezing the pads of the feet of mice to ensure there is no reflex reaction. 3. Explant the lung tissue from the mice using sterile forceps and scissors. Homogenize the lung tissue in 1 mL of 1x phosphate-buffered saline (PBS). 4. Make 10-fold serial dilutions of the lung homogenate in sterile 1x PBS. 5. For plating, spot three aliquots of 20 µL each of the respective dilution on the agar plate. 6. Incubate the plates in an incubator at 37 °C and monitor for bacterial growth. 7. Count the colonies in each spot after the incubation time and express as CFU/ mL by correcting for volume and dilution using the following equation: CFU/ mL = (C/V) x M Where C = colony counts per spot, V = volume of sample inoculated on each plate (mL), and M = multiplication factor (reciprocal of the dilution used). NOTE: If 11 colonies are counted in one spot for a sample volume of 0.002 mL at a sample dilution of 10 -4
, using the equation, the colony count will be calculated as (11/0.02) x 10 4 = 5.5 x 10 6 CFU/ mL 
Discussion
When using imaging techniques, such as REF, there are key strategies that allow generation of robust and consistent data. Optical imaging produces scattered light in tissues which can impact the depth of penetration, since it is difficult to capture light emitted in all directions. Use of a near infra-red fluorophore (NIR) substrate for REF imaging having an excitation and emission wavelength in the Querange of 700 -900 nm facilitates minimal absorption of the fluorescent signal by mammalian tissues. The custom designed substrate was constructed by linking a NIR fluorophore, IRDye 800Cw to a quencher, IRDye QC-1, by a lactam ring allowing fluorescence resonance energy transfer-based quenching. IRDye has excellent tissue penetration and light scattering characteristics and does not have any evident harmful effect on mammals 36 , being cleared from the blood and organs by 24 h. Fluorescence signal significantly increases beginning 4 h after substrate administration, reaching maximal levels 6 h after administration.
The bacterial infectious dose, mode of administration of infectious dose and the substrate as well as time-points of imaging post infection by performing pilot studies should be standardized before embarking on large, complex, experiments. Pilot studies can greatly reduce time and cost when imaging a large number of animals because a standard procedure can be optimized prior to doing the key experiment. Bacterial loads should be determined in the organs/tissues of interest following whole body imaging using trans-illumination and ex vivo lung imaging using epi-illumination to validate the source of the signal and determine the quality of correlation with bacterial numbers present 8 . Pilot studies will provide insight into the threshold of detection, dynamic range of the technique as well as determination of the optimal experimental conditions for imaging. 8, 37 or human clinical materials 29, 38 . REF can be used to detect and image a wide array of pathogens 39, 40 , since fluorogenic substrates can be developed for numerous enzymatic targets other than BlaC such as proteases, kinases, ureases, and β-galactosidases. However, careful thought should be given to the target in order to ensure it displays optimal characteristics for imaging. BlaC represents a good model enzyme for characteristics that will ensure successful application of this strategy. REF imaging provides an immediate read-out on bacterial load present in lungs during infections, which greatly speeds progress in study of tuberculosis pathogenesis, since determination of bacterial numbers normally requires three to six weeks, but even in more rapid-growing organisms this approach will save a great deal of time. REF could also be used to discriminate carcinomas from tuberculosis, a key problem in diagnosis of nodular lesions in patients 41, 42 . REF serves as a novel tool to accelerate translational tuberculosis imaging and can even be applied to humans, potentially allowing rapid prediction of therapeutic outcomes.
